Moreover, heparanase levels correlate with shorter postoperative survival of cancer patients [10,11,12,13] altogether indicating that heparanase is causally involved in cancer progression, encouraging the development of heparanase inhibitors as anti-cancer drugs. Here, HPSE is linked to cancer.